Latvia vs Venezuela, Bolivarian Republic of: Access to anti-retroviral drugs, female
Latvia
54.0%
in 2024
Venezuela, Bolivarian Republic of
54.0%
in 2024
Latvia rank
114th
Venezuela, Bolivarian Republic of rank
114th
Access to anti-retroviral drugs, female over time
- Latvia
- Venezuela, Bolivarian Republic of
How they compare
Latvia currently reports 54.0% against 54.0% in Venezuela, Bolivarian Republic of, a difference of 0.0%.
The two have swapped places 2 times across 23 shared years of data; in 2000 it was Venezuela, Bolivarian Republic of ahead.
Latvia ranks 114th and Venezuela, Bolivarian Republic of ranks 114th of 141 countries.
Venezuela, Bolivarian Republic of has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Venezuela, Bolivarian Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.5% | 18.0% | 15.5% | Venezuela, Bolivarian Republic of |
| 2010s | 20.4% | 49.2% | 28.8% | Venezuela, Bolivarian Republic of |
| 2020s | 50.3% | 53.7% | 3.3% | Venezuela, Bolivarian Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Latvia or Venezuela, Bolivarian Republic of?
- Latvia, at 54.0% against 54.0% in Venezuela, Bolivarian Republic of as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Latvia and Venezuela, Bolivarian Republic of?
- 0.0%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Venezuela, Bolivarian Republic of?
- 23 years are reported by both, from 2000 to 2024.
- How do Latvia and Venezuela, Bolivarian Republic of rank globally for access to anti-retroviral drugs, female?
- Latvia ranks 114th and Venezuela, Bolivarian Republic of ranks 114th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.